This is what's moving AMAR last week.
"The big news: Dr. Joseph Cummins, Amarillo President, and Dr. Manfred Beilharz, a valued AMAR research partner and board member from the University of Western Australia, are leaving almost immediately for Germany. Their mission: To present the Company to European investors.
This is significant because, while a lot of people don’t realize it, the investment community is far different in Europe than it is in America. They don’t have the “middle class” type of investment community that America is fortunate enough to have. Here, nearly everybody is a market participant, if only through an IRA, 401k or whatever. Over there, it’s the moneyed class, not the middle class, that drives the markets. That’s why, when you do see volume in Germany, where AMAR is also listed, it’s big, big volume. That’s because they only have big investors and they bring big, big money when they start buying.
I’m sure Joe will be presenting the Company to some very erudite, very wealthy and well-heeled kind of people – and that’s another point worth mentioning. Joe is a very persuasive speaker and does a superb job of selling the Company. Plus, he knows how to target the audience. I mean, I’ve seen him take the, “aw, shucks, I’m from Texas,” approach when it was called for – and I’ve also seen him talk to Wall Street pros with as much precision and polish as any Fortune 500 CEO. The other power point is that, regardless of the style of his presentation, it’s always imminently obvious that he truly believes what he is saying about oral interferon and AMAR’s technology for applying it. So, I’m sure he’s going to do a very, very good job of presenting the Company to these European investors.
Then there’s Dr. Bielharz. I spent a lot of time getting to know him at AMAR’s annual meeting this past June and we got along really well. He’s very intelligent, very well-educated and has a wonderful sense of humor, as well as a kind of mindful arrogance about him – and I do mean that as a compliment. So, with his credentials and his experience in Australia with his Nobel Prize-winning lab, I think he’ll add a lot of credibility and impact to the presentations they’ll be making in Europe.
Courtesy of The David Stewart Hotline |
